CRISPR Therapeutics AGCRSPNASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank9
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-6.52
↓ 136% vs avg
Percentile
P9
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
-2.76
Historical baseline
PeriodValueYoY Change
TTM-6.52-50.2%
2024-4.34-123.7%
2023-1.94+76.8%
2022-8.36-277.9%
20214.70+188.8%
2020-5.29-552.1%
20191.17+134.0%
2018-3.44-101.2%
2017-1.71+9.5%
2016-1.89-